The warning landed like a punch. A leading quit-smoking drug, trusted for years, is suddenly being pulled back over potential cancer risks. Patients are scared. Doctors are scrambling. And regulators are racing against time to explain what went wrong. As hidden chemicals, quiet recalls, and unanswered questions collide, the story behind this “safe” pill is only just beg… Continues…